Carregant...
Belimumab in systemic lupus erythematosus: a perspective review
Belimumab (Benlysta(®)) is a fully humanized monoclonal antibody that inhibits B-lymphocyte stimulator (also known as B cell activating factor of the tumor necrosis factor family) and was approved by the US Food and Drug Administration and the European Medicines Evaluation Agency for treatment of au...
Guardat en:
| Publicat a: | Ther Adv Musculoskelet Dis |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530384/ https://ncbi.nlm.nih.gov/pubmed/26288663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X15588514 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|